30 June 2026, Indianapolis: Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future publicly traded, advanced seed and genetics company that will result from the current company’s planned separation.
Karen Grimes will lead the board as Independent Chair. Grimes joined Corteva’s board of directors in March 2021 and was previously senior managing director, partner, and equity portfolio manager at Wellington Management Company LLP, an investment management firm. She began her career as a field engineer in the Atlanta office at IBM after serving for three years in the U.S. Army. Grimes also serves as a director of Toll Brothers, Inc., a company that develops and builds luxury residential communities across the U.S., since March 2019.
“Vylor will be a company dedicated to leveraging its expertise in advanced seed and genetics to help farmers feed and fuel the world. I look forward to working with my fellow directors as well as the Vylor senior management team to accelerate the company’s growth and impact – and continue to deliver results for shareholders,” said Grimes.
The appointments to the board of seven directors will be effective at separation, which remains on track for the fourth quarter of 2026. A search is ongoing for at least one additional board member.
The Future Vylor Board of Directors
Karen Grimes, retired partner, senior managing director and equity portfolio manager, Wellington Management Company, non-executive chair of the board
Victor Aguilar, chief research, development and innovation officer, The Procter & Gamble Company
Rajesh “Raj” Kalathur, Rajesh “Raj” Kalathur, former president, John Deere Financial, former chief information officer and chief financial officer, Deere & Company
Marcos Lutz, chairman, former chief executive officer, Ultrapar Participacões S.A.
Johannes “Jannie” J. Oosthuizen, executive vice president and president, oncology and MSD International, Merck & Co., Inc.
Kerry Preete, retired executive vice president and chief strategy officer, Monsanto Company
Vylor’s innovation engine will be anchored in the agriculture industry’s most elite germplasm and transformative biotech. The company will leverage its next generation scientific expertise in disciplines like gene editing and molecular breeding to further strengthen its core business while exploring opportunities to expand to new row crops – and potentially beyond. Vylor will scale these innovations using its leading routes-to-market and by significantly expanding its licensing business.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
